Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07350577 · ClinicalTrials.gov registry record · Phase 1

Evaluate the Safety, Tolerability, PK and PD of SAD of Intravenously Adminsterted ALTB-268 in Healthy Participants

A Phase 1 study of Ulcerative Colitis (UC), sponsored by AltruBio.

Recruiting
Registry status
Phase 1
Development phase
24
Enrollment target
1
Study location

NCT07350577 is a Phase 1 study of Ulcerative Colitis (UC) that is actively recruiting participants, run by AltruBio. The registered enrollment target is 24 participants, below the 763-participant average among 17 other Ulcerative Colitis (UC) trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07350577, a Phase 1 study of Ulcerative Colitis (UC), is actively recruiting participants, sponsored by AltruBio.

RECRUITING
Registry status
Phase 1
Development phase
24 participants
Enrollment target
1
Study location

Study Summary

This study with ALTB-268 will determine the safety, tolerability, pharmacokinetics and pharmacodynamics of single ascending doses of intravenously administrated ALTB-268 in healthy participants.

Conditions Studied

Ulcerative Colitis (UC)

Interventions

  • OTHER Placebo
  • BIOLOGICAL ALTB-268

Study Locations (1)

Florida

  • Syneos Health Clinical Research Services, LLC - Miami

Trial Details

FieldValue
Enrollment Target 24 participants
Start Date 2025-11-17
Est. Completion 2026-07-28
Phase Phase 1

Sponsor

AltruBio

5 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT07350577

The ClinicalTrials.gov registry entry for NCT07350577 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 763-participant average among 17 other Ulcerative Colitis (UC) trials with a reported enrollment target (97% lower). The listed sponsor is AltruBio, which has 5 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Ulcerative Colitis (UC) appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT07350577 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT07350577 about?

NCT07350577 is a clinical study titled "Evaluate the Safety, Tolerability, PK and PD of SAD of Intravenously Adminsterted ALTB-268 in Healthy Participants". This study with ALTB-268 will determine the safety, tolerability, pharmacokinetics and pharmacodynamics of single ascending doses of intravenously administrated ALTB-268 in healthy participants.

What is the current status of trial NCT07350577?

This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 24 participants. The study started on 2025-11-17. Estimated completion is 2026-07-28.

What conditions does trial NCT07350577 study?

This clinical trial studies the following conditions: Ulcerative Colitis (UC).

What interventions are being tested in trial NCT07350577?

The interventions under investigation include: Placebo (OTHER), ALTB-268 (BIOLOGICAL).

Who is sponsoring clinical trial NCT07350577?

This trial is sponsored by AltruBio, which has 5 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07350577 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Ulcerative Colitis (UC)

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Ulcerative Colitis (UC)

All registered trials for this condition

Florida

All trials with a study site in Florida

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.